Impact of <scp>SARS</scp>‐<scp>CoV‐</scp>2 infection and <scp>COVID</scp>‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain
This study shows a high risk of severe COVID-19 amongst ALS patients requiring NIV. Nevertheless, the pandemic showed no impact in the overall survival of ALS patients, probably due to a high vaccination rate and an adequate access to healthcare resources.
Authors
- Teresa Sevilla (ORCID: https://orcid.org/0000-0003-4716-2667)
- Juan F. Vázquez‐Costa (ORCID: https://orcid.org/0000-0002-3043-7938)
- Pablo Pérez‐Martínez (ORCID: https://orcid.org/0000-0001-7716-8117)
- Pilar H. García‐Casanova (ORCID: https://orcid.org/0000-0003-1204-4150)
- Montserrat León
- Rosalía Doménech
Institutions
- Universitat de València (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Clínico Universitario de Valencia (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Investigación Sanitaria La Fe (ES)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1111/ene.16465
- Citations
- 3
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Instituto de Salud Carlos III